Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: VR-PAT During Home Burn Dressings - Multisite [NA]
A multisite clinical trial evaluating VR-PAT for pain management during home burn dressings is currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ Leukemia [Phase 1]
Phase 1 pilot study evaluating T-APCs after CAR T cell immunotherapy for CD19-positive acute leukemia is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic Leukemia [Phase 1]
Phase 1 pediatric trial evaluating autologous CD19-directed CAR-T cells for relapsed CD19-positive acute lymphoblastic leukemia.
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: A Study of Venetoclax in Combination With Chemotherapy to Treat Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) [EARLY_Phase 1]
An update on a phase 1 study of venetoclax with chemotherapy for newly diagnosed Acute Lymphoblastic Leukemia, currently not recruiting.
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Feasibility of a Life Coping Program: A Study Protocol [NA]
Completed study protocol reporting the feasibility of a life coping program to improve health-related quality of life and health literacy, w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies [Phase 1]
Phase 1 trial update describing the use of allogeneic Epstein-Barr virus-specific cytotoxic T-lymphocytes targeted to CD19 for B-cell malign…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 clinical trial evaluating treatment for newly diagnosed high-risk pediatric acute lymphoblastic leukemia; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children [Phase 2]
This entry describes a Phase 2 clinical trial evaluating treatment for newly diagnosed standard-risk acute lymphoblastic leukemia in childre…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea [Phase 2]
A Phase 2 clinical trial in Korea evaluating treatment for pediatric patients with very high-risk acute lymphoblastic leukemia is currently …
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia [Phase 2]
Ongoing Phase 2 clinical trial evaluating treatment efficacy by risk group in relapsed childhood acute lymphoblastic leukemia, currently rec…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies
A clinical trial is investigating the effectiveness and safety of the CAR-T therapy tisagenlecleucel in Brazilian patients with B-lymphocyte…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia [NA]
A clinical trial evaluating a CD7-targeted CAR-T cell therapy for relapsed/refractory CD7-positive T-cell lymphoma and CD7-positive acute ly…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating post-transplant use of inotuzumab ozogamicin for acute lymphoblastic leukemia; the study is currently recru…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial is evaluating CD19 CAR-T consolidation therapy for adult B-cell acute lymphoblastic leukemia, and the study…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Pediatric Vaccinations
This entry notes an ongoing clinical trial sponsored by NYU Langone Health exploring pediatric vaccination approaches, including considerati…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL [Phase 1, Phase 2]
A Phase 1/Phase 2 trial at Dana-Farber Cancer Institute is evaluating Venetoclax plus chemotherapy as frontline therapy for older patients a…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis [Phase 2]
A Phase 2 trial (ABBA CORD) evaluating donor-derived cord blood T cells with abatacept for prophylaxis of acute graft-versus-host disease in…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: European Prospective Investigation Into Childhood Cancer
The European Prospective Investigation Into Childhood Cancer trial is currently recruiting, studying acute lymphoblastic leukemia and brain …
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants [Phase 2]
Phase 2 clinical trial update describing the addition of itacitinib to cyclophosphamide and tacrolimus for preventing graft-versus-host dise…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma [NA]
A clinical trial is evaluating intravenous autologous CD19 CAR-T cells for relapsed or refractory lymphoblastic leukemia and relapsed/refrac…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 [Phase 1]
Phase 1 study of autologous CD19-targeted CAR-T cells for precursor B-cell acute lymphoblastic leukemia. The trial status is active but not …
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance [Phase 1, Phase 2]
A Phase 1/2 study of blinatumomab in patients with Pre-B cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma as remission main…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 clinical trial evaluating a bortezomib-based regimen for refractory or relapsed acute lymphoblastic leukemia, currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS [Phase 2]
This clinical trial update describes a Phase 2 study evaluating palliative care oncology in adults with relapsed, refractory, or high-risk a…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients [NA]
This clinical trial update indicates that UCSF is recruiting for a study titled Health Advocate for Liver Transplantation, aimed at improvin…